{
    "clinical_study": {
        "@rank": "75695", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Standard care postoperatively."
            }, 
            {
                "arm_group_label": "Teriparatide", 
                "arm_group_type": "Experimental", 
                "description": "One injection daily for 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Parathyroid (PTH) hormone has been shown to enhance fracture healing in animal studies.\n      There are so far only three published papers concerning humans. Postero-lateral fusions have\n      shown a healing rate of less than 50% after bone. The purpose of this study is to determine\n      if PTH 1-34 (teriparatide) improves the healing rate and the clinical course after spinal\n      stenosis surgery."
        }, 
        "brief_title": "Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Spinal Stenosis", 
        "condition_browse": {
            "mesh_term": [
                "Constriction, Pathologic", 
                "Spinal Stenosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "100 patients undergoing surgery due to spinal stenosis and intraoperatively treated with\n      autologous bone graft, will be randomised to either 4 weeks of daily injections with\n      teriparatide or control.\n\n      Primary outcome: The rate of healing at 6 months on CT Scans. Secondary outcomes; Pain\n      (VAS), function (Oswestry Disability Index), quality of life (EQ-5D) at 3 and 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  lumbar spinal stenosis operated on with decompression and bone grafting. All ages are\n             accepted, but women must be postmenopausal.\n\n        Exclusion Criteria:\n\n          -  \u2022dementia or psychiatric disorder\n\n               -  known malignancy < 5 years prior to fracture\n\n               -  calcium above reference value\n\n               -  signs of liver disease\n\n               -  creatinine over ref. value\n\n               -  inflammatory joint disease\n\n               -  alcohol or drug abuse\n\n               -  oral corticosteroid medication\n\n               -  long-term NSAID-treatment (=> 3 months prior to fracture)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02090244", 
            "org_study_id": "PTH spinal stenosis", 
            "secondary_id": "2011-002917-12"
        }, 
        "intervention": {
            "arm_group_label": "Teriparatide", 
            "description": "Daily injections with teriparatide 20 \u00b5g (PTH 1-34 (Forteo\u00ae)) during four weeks", 
            "intervention_name": "Teriparatide", 
            "intervention_type": "Drug", 
            "other_name": "Forteo"
        }, 
        "intervention_browse": {
            "mesh_term": "Teriparatide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PTH", 
            "Spinal stenosis", 
            "Teriparatide"
        ], 
        "lastchanged_date": "March 16, 2014", 
        "location": [
            {
                "contact": {
                    "email": "patrik.bernestra@ltkalmar.se", 
                    "last_name": "Patrik Bernestr\u00e5, MD", 
                    "phone": "+46-48081332"
                }, 
                "facility": {
                    "address": {
                        "city": "Kalmar", 
                        "country": "Sweden"
                    }, 
                    "name": "Ortopedkliniken"
                }, 
                "investigator": {
                    "last_name": "Patrik Bernestra, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jon.ottesen@lio.se", 
                    "last_name": "Jon Ottesen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "581 85"
                    }, 
                    "name": "Ryggkliniken, US Link\u00f6ping"
                }, 
                "investigator": {
                    "last_name": "Jon Ottesen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "F\u00f6rb\u00e4ttrar PTH Postero-lateral fusionsl\u00e4kning Vid Ryggkirurgi?", 
        "overall_contact": {
            "email": "torsten.johansson@lio.se", 
            "last_name": "Torsten Johansson, MD PhD", 
            "phone": "+46-10-1034262"
        }, 
        "overall_official": [
            {
                "affiliation": "Ryggkliniken, US Link\u00f6ping", 
                "last_name": "Jon Ottesen, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ortopedkliniken, Kalmar, Sweden", 
                "last_name": "Patrik Bernestr\u00e5, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The rate of bone healing after spinal stenosis surgery", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02090244"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Linkoeping", 
            "investigator_full_name": "Torsten Johansson", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital, Linkoeping", 
        "sponsors": {
            "collaborator": {
                "agency": "Medical Research Council of Southeast Sweden", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital, Linkoeping", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}